Investor Atlas

2080 Ventures · Investor research

46 investors focused on Biotech targeting Singapore

Compare 46 investors focused on Biotech targeting Singapore. Review the selection, investor types and reported focus with 2080 Ventures.

46matching investors
4individual investors
42organizations

What this selection covers

This guide contains 46 distinct directory identities matching target markets: Singapore; sectors: Biotech. Counts describe Investor Atlas coverage, not the size of the market or currently available capital.

“Targeting Singapore” means the source explicitly lists this investment market. These investors may be headquartered elsewhere. Worldwide or regional labels are not expanded into individual countries.

Investor types represented: Venture Capital (37), Angel Investor (4), Corporate Venture Capital (4), Family Office (3).

Prepare a focused approach

Explain the development pathway, validation milestones and capital needed to reach the next evidence point.

Before pitching for Singapore, confirm incorporation requirements, team location and whether the mandate supports market entry or only established local operations.

  1. Check the current mandate and recent investments.
  2. Confirm check size, lead or follow preference, and company eligibility.
  3. Identify the relevant partner and published pitch route.
  4. Explain your customer evidence, raise and specific reason for approaching this investor.

Explore the 46 matching investors

Listed alphabetically, without ranking by performance or likelihood of investment. Full profiles, investment criteria and available contact details require sign-in.

InvestorInvestor typeResearch
5AM Ventures
Venture CapitalView profile ↗
Alumni Ventures
Venture CapitalView profile ↗
Amadeus Capital Partners
Venture CapitalView profile ↗
Amy Chen
Angel InvestorView profile ↗
Antler
Venture CapitalView profile ↗
Arcanum Ventures
Venture CapitalView profile ↗
Ardian
Private EquityView profile ↗
B Capital Group
Venture CapitalView profile ↗
Bain Capital
Venture CapitalView profile ↗
Boehringer Ingelheim Venture Fund
Venture Capital, Corporate Venture CapitalView profile ↗
Boost VC
Venture Capital, AcceleratorView profile ↗
Cherubic Ventures
Venture CapitalView profile ↗
Compound
Venture CapitalView profile ↗
Craig Ready
Angel InvestorView profile ↗
Deepbridge Capital
Venture CapitalView profile ↗
EVX Ventures
Venture CapitalView profile ↗
Fiddlehead Ventures
Venture CapitalView profile ↗
Flagship Pioneering
Venture CapitalView profile ↗
Flashpoint VC
Venture CapitalView profile ↗
Future Planet Capital
Venture CapitalView profile ↗
General Atlantic
Venture CapitalView profile ↗
Global Founders Capital
Venture Capital, Family OfficeView profile ↗
Gobi Partners
Venture CapitalView profile ↗
Granite Asia
Venture CapitalView profile ↗
Great Eagle Holdings
Corporate Venture CapitalView profile ↗
Harriet Ventures
Private EquityView profile ↗
Hummingbird Ventures
Venture CapitalView profile ↗
iGlobe Partners
Venture CapitalView profile ↗
Index Ventures
Venture CapitalView profile ↗
IndieBio
Venture CapitalView profile ↗
K for Capital
Family OfficeView profile ↗
Khosla Ventures
Venture CapitalView profile ↗
Lightstone Ventures
Venture CapitalView profile ↗
Luka Novak
Angel InvestorView profile ↗
Michael Wieser
Angel InvestorView profile ↗
NEFES Holding
Venture CapitalView profile ↗
Novartis Venture Fund
Venture Capital, Corporate Venture CapitalView profile ↗
Novo Holdings
Venture Capital, Corporate Venture CapitalView profile ↗
Pioneer Fund
Venture Capital, SyndicateView profile ↗
Polaris Partners
Venture CapitalView profile ↗
Pureos Bioventures
Venture CapitalView profile ↗
Sentor Investments
Family OfficeView profile ↗
SGInnovate
Venture CapitalView profile ↗
SV Health Investors
Venture CapitalView profile ↗
True Ventures
Venture CapitalView profile ↗
Western Technology Investment
Venture CapitalView profile ↗

How these guides are compiled. Source-reported criteria may change. A listing does not confirm current investment activity.